Home > Business, Equities, Europe, Health Care > Crucell NV. (NASDAQ:CRXL) – The common stock achieved our target price on 01 August 2008. Free research report.

Crucell NV. (NASDAQ:CRXL) – The common stock achieved our target price on 01 August 2008. Free research report.

In our 1Q 08 update report, dated 17 July 2008, we reiterated the Crucell N.V. (Crucell) common stock a BUY with a target price of €10.65, representing an upside of 16%. The common stock achieved our target price on 01 August 2008, closing at €11.01. Consequently, we are downgrading the common stock from a BUY to a HOLD as the current price no longer supports our BUY rating. We reiterate the ADR a HOLD based on our fundamental outlook and our expectation of a negative currency impact in the long term.

Read the full report free of charge with free to view access to institutional-quality research on 400 companies and over 700 stocks at www.researchoracle.com

Become a fan on Facebook

  1. No comments yet.
  1. No trackbacks yet.
Business Directory for London, London
107